Subscribe to Newsletter


Business & Regulation Biosimilars

WHO Wants Cancer Biosimilars

| James Strachan

Will a pilot project to prequalify “generic” biologics improve safe access to medicines?

Discovery & Development Biosimilars

The Power List 2017

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Manufacture Analytical Science

Bringing Time Back to Biology

| Robert Karlsson

Surface plasmon resonance has become a go-to tool for biotherapeutic characterization.

Business & Regulation Biosimilars

Why Are We Still Waiting for Biosimilars?

| Robert Wessman

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Discovery & Development Biosimilars

Proving Biosimilarity

| Fiona Greer

Sitting Down With... Fiona Greer, a biosimilar guru from SGS.

Business & Regulation Biosimilars

Russian Revolution for Biosimilars

| Roman Ivanov

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

Manufacture Analytical Science

Standing Up for Microcalorimetry

| Natalia Markova

We investigate the advantages and limitations of microcalorimetry in biopharma.

Business & Regulation Biosimilars

Biosimilars, Come Fly With Me

| Catherine Godrecka-Bareau

How inspiration from the airline industry could help improve the biosimilars industry.

Manufacture Biosimilars

Why Share Your Biosimilars Cake?

| Guillaume Plane

Biosimilar drugmakers should remember that the best cake is one that doesn't have to be shared.

Manufacture Biosimilars

Generics Deliver Savings

| James Strachan

Our infographic shows how much can be saved with generic drugs

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine